Rivaroxaban Outmatched by VKAs for AF in Rheumatic Heart Disease ...Middle East

Medscape - News
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS trial at ESC 2022. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Rivaroxaban Outmatched by VKAs for AF in Rheumatic Heart Disease )

Apple Storegoogle play

Also on site :